CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- SD Other Specialized Disclosure
- 4 Open-market sale Executive VP Global Operations sold 16,070 shares at $11.42 ($183,519)
- 4 Open-market sale Executive VP Global Operations sold 629 shares at $11.76 ($7,397)
- 4 Option exercise Director acquired 2,780 shares (option exercise)
- 4 Option exercise Director acquired 2,780 shares (option exercise)
- 4 Option exercise Director acquired 2,780 shares (option exercise)
- 4 Option exercise Director acquired 2,780 shares (option exercise)
- 4 Option exercise Director acquired 2,780 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market sale EVP, North America Commercial sold 1,179 shares at $16.63 ($19,601)
- 4 Open-market sale EVP, Growth Markets Commercial sold 320 shares at $16.64 ($5,326)
- 4 Open-market sale Exec. VP, European Commercial sold 1,297 shares at $16.64 ($21,588)
- 4 Open-market sale Exec. VP Chief Legal Officer sold 2,358 shares at $16.43 ($38,742)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 41 of 128 · 2,555 filings